Exane Derivatives’s Pluralsight, Inc. Class A Common Stock PS Stock Holding History

Exane Derivatives’s Portfolio PS Stock Details PS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,526	Closed	-$78.8K	–	1097
2021 Q1	$78.8K	Sell	3,526 -21,062	-86%	-$452K	0.02%	456
2020 Q4	$515K	Buy	24,588 +146	+0.6%	+$2.61K	0.15%	149
2020 Q3	$419K	Buy	24,442 +2,784	+13%	+$53.3K	0.12%	150
2020 Q2	$391K	Buy	+21,658	New	+$367K	0.1%	171

Other funds holding PS

SCA

Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return

Exane Derivatives's PS Position: Q2 2021 in Review

Exane Derivatives sold out of Pluralsight, Inc. Class A Common Stock (PS) in Q2 2021, closing a stake of 3,526 shares — an estimated $78.8K sold.

Exane Derivatives first reported a position in PS in Q2 2020 and held it in 4 quarters. The position peaked at $515K in Q4 2020. 1 fund tracked by Wall St. Rank holds PS as of Q2 2021.

Exane Derivatives reported no remaining Pluralsight, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 3,526 Pluralsight, Inc. Class A Common Stock shares in Q2 2021, an estimated $78.8K.
Exane Derivatives first reported a position in Pluralsight, Inc. Class A Common Stock in Q2 2020 and held it in 4 quarters.
Exane Derivatives's Pluralsight, Inc. Class A Common Stock position peaked at $515K in Q4 2020.
1 fund tracked by Wall St. Rank held Pluralsight, Inc. Class A Common Stock as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.